We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-1.18%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.86B
AUM Growth
+$362M
Cap. Flow
+$499M
Cap. Flow %
10.26%
Top 10 Hldgs %
17.76%
Holding
548
New
154
Increased
98
Reduced
117
Closed
170

Top Buys

Rank Stock Value
1
CRR
Carbo Ceramics Inc.
CRR
+$50.9M
2
BHI
Baker Hughes
BHI
+$50M
3
SHPG
Shire pic
SHPG
+$49.7M
4
CNQR
CONCUR TECHNOLOGIES INC
CNQR
+$49.3M
5
MLM icon
Martin Marietta Materials
MLM
+$42.5M

Top Sells

Rank Stock Value
1
AMSG
Amsurg Corp
AMSG
+$72.9M
2
VISN
Vistance Networks Inc
VISN
+$35.4M
3
TKR icon
Timken Company
TKR
+$34.1M
4
QCOR
QUESTCOR PHARMA INC
QCOR
+$33.8M
5
DHR icon
Danaher
DHR
+$33.6M

Sector Composition

Rank Sector Weight
1 Healthcare 12.84%
2 Financials 10.91%
3 Industrials 10.79%
4 Energy 9.19%
5 Consumer Discretionary 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ATRC icon
351
AtriCure
ATRC
$2.11B
$672K 0.01%
45,625
-207,282
-82% -$3.3M
LOXO
352
DELISTED
Loxo Oncology, Inc
LOXO
$662K 0.01%
+50,449
New +$655K
AFMD
353
DELISTED
Affimed
AFMD
$630K 0.01%
+10,000
New +$624K
RVNC
354
DELISTED
Revance Therapeutics, Inc.
RVNC
$626K 0.01%
32,360
-27,640
-46% -$720K
GEVO icon
355
Gevo
GEVO
$382M
$537K 0.01%
+261
New +$868K
EVDY
356
DELISTED
Everyday Health, Inc.
EVDY
$534K 0.01%
+38,216
New +$608K
MANU icon
357
Manchester United
MANU
$3.73B
$522K 0.01%
+31,656
New +$553K
AERI
358
DELISTED
Aerie Pharmaceuticals
AERI
$516K 0.01%
+24,927
New +$491K
QNST icon
359
QuinStreet
QNST
$1.21B
$489K 0.01%
117,797
-5,572
-5% -$27.4K
AGTC
360
DELISTED
Applied Genetic Technologies Corporation
AGTC
$481K 0.01%
+25,827
New +$468K
VCRA
361
DELISTED
VOCERA COMMUNICATIONS, INC.
VCRA
$481K 0.01%
59,630
+47,624
+397% +$483K
LINC icon
362
Lincoln Educational Services
LINC
$1.3B
$434K 0.01%
154,280
+35,124
+29% +$111K
ADMS
363
DELISTED
Adamas Pharmaceuticals
ADMS
$409K 0.01%
21,978
-28,223
-56% -$486K
MBII
364
DELISTED
Marrone Bio Innovations, Inc.
MBII
$334K 0.01%
125,412
-253,059
-67% -$1.69M
TLOG
365
DELISTED
TetraLogic Pharmaceuticals Corporation
TLOG
$329K 0.01%
79,196
-3,747
-5% -$17.5K
FATE icon
366
Fate Therapeutics
FATE
$326M
$263K 0.01%
51,482
+405
+0.8% +$2.34K
CYTK icon
367
CALL
Cytokinetics
CYTK
$10.4B
$232K ﹤0.01%
65,789
– –
GNCA
368
DELISTED
Genocea Biosciences, Inc.
GNCA
$226K ﹤0.01%
+3,125
New +$342K
XNCR icon
369
Xencor
XNCR
$1.55B
$220K ﹤0.01%
+23,667
New +$239K
MGNX icon
370
MacroGenics
MGNX
$257M
$218K ﹤0.01%
10,435
-60,685
-85% -$1.26M
CBIO
371
Crescent Biopharma
CBIO
$626M
$209K ﹤0.01%
301
-4
-1% -$3.24K
AGRX
372
DELISTED
Agile Therapeutics
AGRX
$189K ﹤0.01%
13
-76
-85% -$1.17M
EIGR
373
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$150K ﹤0.01%
+32
New +$169K
AKAO
374
DELISTED
Achaogen Inc
AKAO
$120K ﹤0.01%
13,414
-635
-5% -$6.5K
QURE icon
375
uniQure
QURE
$3.22B
$111K ﹤0.01%
12,050
-570
-5% -$6.26K
13 14
15
16 17

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q3 2014 Portfolio in Review

As of Q3 2014, Alyeska Investment Group held 548 positions worth $4.86B, up 8% from $4.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $499M of net new capital in Q3 2014, opening 154 new positions and adding to 98 existing holdings. Its largest new stake was Carbo Ceramics Inc.: 446,143 shares worth $26.4M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Vistance Networks Inc, an estimated $35.4M trimmed.

  • Alyeska Investment Group's largest Q3 2014 buy was Carbo Ceramics Inc.: 446,143 shares worth $26.4M.
  • Alyeska Investment Group added most to DIRECTV COM STK (DE) in Q3 2014, an estimated $38.9M increase.
  • Alyeska Investment Group's biggest Q3 2014 reduction was Vistance Networks Inc, cutting an estimated $35.4M.
  • Alyeska Investment Group fully exited Amsurg Corp in Q3 2014, selling an estimated $72.9M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $4.86B portfolio in Q3 2014.
  • Alyeska Investment Group opened 154 new positions and closed 170 in Q3 2014.
  • Alyeska Investment Group's portfolio value rose 8% quarter-over-quarter to $4.86B.

Based on Alyeska Investment Group's 13F filing for Q3 2014, filed 14 Nov 2014.